Cui Cui
Stock Analyst at Jefferies
(4.48)
# 1,107
Out of 5,076 analysts
35
Total ratings
57.6%
Success rate
31.6%
Average return
Main Sectors:
Stocks Rated by Cui Cui
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HKG: 2269 WuXi Biologics (Cayman) Inc. | Reiterated: Buy | $45.00 → $60.00 | $45.80 | +31.00% | 2 | Aug 27, 2026 | |
| HKG: 1548 Genscript Biotech Corporation | Reiterated: Buy | $15.50 → $30.00 | $31.60 | -5.06% | 2 | Aug 20, 2026 | |
| HKG: 6618 JD Health International Inc. | Reiterated: Buy | $88.00 → $80.00 | $37.60 | +112.77% | 4 | Aug 17, 2026 | |
| HKG: 0241 Alibaba Health Information Technology Limited | Reiterated: Buy | $8.00 → $5.30 | $2.87 | +84.99% | 2 | May 19, 2026 | |
| HKG: 9966 Alphamab Oncology | Reiterated: Buy | $9.60 | $6.63 | +44.80% | 1 | Mar 27, 2026 | |
| HKG: 1833 Ping An Healthcare and Technology Company Limited | Reiterated: Hold | $12.40 | $5.53 | +124.43% | 1 | Mar 25, 2026 | |
| HKG: 9926 Akeso, Inc. | Reiterated: Buy | $226.00 | $86.60 | n/a | 3 | Oct 19, 2025 | |
| HKG: 9606 Duality Biotherapeutics, Inc. | Reiterated: Buy | $500.00 | $149.70 | n/a | 2 | Oct 8, 2025 | |
| HKG: 6990 Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. | Reiterated: Buy | $300.00 → $520.00 | $460.40 | n/a | 3 | Aug 19, 2025 | |
| HKG: 1093 CSPC Pharmaceutical Group Limited | Reiterated: Sell | $5.00 | $8.35 | n/a | 1 | Jul 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $41.00 → $60.00 | $71.30 | n/a | 2 | Mar 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $175.00 → $87.40 | $186.00 | n/a | 2 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40.00 | $83.20 | n/a | 1 | Jan 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4.00 | $2.22 | n/a | 1 | Jan 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10.80 | $6.05 | n/a | 1 | Jan 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $26.00 | $15.34 | n/a | 1 | Nov 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $110.00 | $37.94 | n/a | 1 | Oct 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40.00 → $35.20 | $20.70 | n/a | 2 | Oct 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $28.00 → $25.00 | $33.00 | n/a | 2 | Sep 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $10.00 | $14.06 | n/a | 1 | Apr 22, 2020 |
WuXi Biologics (Cayman) Inc.
Aug 27, 2026
Reiterated: Buy
Price Target: $45.00 → $60.00
Current: $45.80
Upside: +31.00%
Genscript Biotech Corporation
Aug 20, 2026
Reiterated: Buy
Price Target: $15.50 → $30.00
Current: $31.60
Upside: -5.06%
JD Health International Inc.
Aug 17, 2026
Reiterated: Buy
Price Target: $88.00 → $80.00
Current: $37.60
Upside: +112.77%
Alibaba Health Information Technology Limited
May 19, 2026
Reiterated: Buy
Price Target: $8.00 → $5.30
Current: $2.87
Upside: +84.99%
Alphamab Oncology
Mar 27, 2026
Reiterated: Buy
Price Target: $9.60
Current: $6.63
Upside: +44.80%
Ping An Healthcare and Technology Company Limited
Mar 25, 2026
Reiterated: Hold
Price Target: $12.40
Current: $5.53
Upside: +124.43%
Akeso, Inc.
Oct 19, 2025
Reiterated: Buy
Price Target: $226.00
Current: $86.60
Upside: n/a
Duality Biotherapeutics, Inc.
Oct 8, 2025
Reiterated: Buy
Price Target: $500.00
Current: $149.70
Upside: n/a
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Aug 19, 2025
Reiterated: Buy
Price Target: $300.00 → $520.00
Current: $460.40
Upside: n/a
CSPC Pharmaceutical Group Limited
Jul 30, 2025
Reiterated: Sell
Price Target: $5.00
Current: $8.35
Upside: n/a
Mar 27, 2025
Reiterated: Buy
Price Target: $41.00 → $60.00
Current: $71.30
Upside: n/a
Mar 21, 2025
Reiterated: Buy
Price Target: $175.00 → $87.40
Current: $186.00
Upside: n/a
Jan 22, 2025
Reiterated: Buy
Price Target: $40.00
Current: $83.20
Upside: n/a
Jan 22, 2025
Reiterated: Buy
Price Target: $4.00
Current: $2.22
Upside: n/a
Jan 22, 2025
Reiterated: Buy
Price Target: $10.80
Current: $6.05
Upside: n/a
Nov 3, 2023
Reiterated: Buy
Price Target: $26.00
Current: $15.34
Upside: n/a
Oct 31, 2023
Reiterated: Buy
Price Target: $110.00
Current: $37.94
Upside: n/a
Oct 27, 2023
Reiterated: Buy
Price Target: $40.00 → $35.20
Current: $20.70
Upside: n/a
Sep 4, 2023
Reiterated: Buy
Price Target: $28.00 → $25.00
Current: $33.00
Upside: n/a
Apr 22, 2020
Downgraded: Hold
Price Target: $10.00
Current: $14.06
Upside: n/a